Standout Papers

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection i... 1997 2026 2006 2016 706
  1. Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America (2003)
    Jacob Lalezari, Keith Henry et al. New England Journal of Medicine
  2. Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection (1997)
    Winston Cavert, Daan W. Notermans et al. Science

Immediate Impact

4 by Nobel laureates 38 from Science/Nature 79 standout
Sub-graph 1 of 13

Citing Papers

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
2019 Standout
Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1
2019 Standout
29 intermediate papers

Works of Keith Henry being referenced

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
2015
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
2012
and 10 more

Author Peers

Author Last Decade Papers Cites
Keith Henry 4379 3891 1838 135 7.1k
Roland Tubiana 3981 3703 2000 150 6.1k
Kathleen Squires 5054 4334 1646 81 6.9k
Kiat Ruxrungtham 5253 3768 2398 314 8.5k
Jennifer Hoy 5169 3151 2788 234 8.1k
Courtney V. Fletcher 5317 4089 2082 226 8.2k
Charles C. J. Carpenter 6660 4370 2628 135 10.8k
John Bartlett 4460 2401 1876 191 7.1k
Milos Opravil 4422 3551 2290 143 7.1k
Donna Mildvan 5293 3684 3845 128 9.4k
Laurence Meyer 4177 4406 2166 276 7.7k

All Works

Loading papers...

Rankless by CCL
2026